Clinical Trials List
2019-03-06 - 2022-02-28
Phase II
Recruiting7
Terminated2
ICD-10C34
Malignant neoplasm of bronchus and lung
ICD-9162.0
Malignant neoplasm of trachea
-
Trial Applicant
AbbVie
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- 徐偉勛 Division of Hematology & Oncology
- 廖唯昱 Division of Hematology & Oncology
- James Chih-Hsin Yang Division of Hematology & Oncology
- Chong-Jen Yu Division of Hematology & Oncology
- 許嘉林 Division of Hematology & Oncology
- 廖斌志 Division of Hematology & Oncology
- JIN-YUAN SHIH Division of Hematology & Oncology
- Jih-Hsiang Lee Division of Hematology & Oncology
- CHAO-CHI HO CHAO-CHI HO Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Audit
None
Co-Principal Investigator
- Wen-Pin Su Division of Hematology & Oncology
- Xin-Min Liao Division of Hematology & Oncology
- Wei-Pang Chung Division of Hematology & Oncology
- Yi-Ting Yen Division of Hematology & Oncology
- Chien-Chung Lin Division of Hematology & Oncology
- Jui-Hung Tsai Division of Hematology & Oncology
- Wu-Chou Su Division of Hematology & Oncology
- Po-Lan Su Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Audit
None
Co-Principal Investigator
- 陳焜結 Division of Thoracic Medicine
- JENG-SEN TSENG Division of Thoracic Medicine
- 徐國軒 Division of Thoracic Medicine
- YEN-HSIANG HUANG Division of Thoracic Medicine
- KUO-HSUAN HSU 未分科
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 柯皓文 Division of Hematology & Oncology
- Wen-Cheng Chang Division of Hematology & Oncology
- Chih-Liang Wang Division of Hematology & Oncology
- Chien-Ying Liu Division of Hematology & Oncology
- Ping-Chih Hsu Division of Hematology & Oncology
- 吳振德 Division of Radiology
- Chih-Hung Chen Division of Hematology & Oncology
- Cheng-Ta Yang Division of Hematology & Oncology
- 枋岳甫 Division of Hematology & Oncology
- 黃振洋 Division of Hematology & Oncology
- Chih-Hung Chen Division of Hematology & Oncology
- Shih-Hong Li Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Ching-Shan Luo Division of Hematology & Oncology
- YEN-HAN TSENG Division of Hematology & Oncology
- Po-Hao Feng Division of Hematology & Oncology
- YUN-KAI YEH Division of Hematology & Oncology
- Tzu-Tao Chen Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 李玫萱 Division of Thoracic Medicine
- Ying-Ming Tsai Tsai Division of Thoracic Medicine
- 郭家佑 Division of Thoracic Medicine
- Jui-Ying Lee Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Shau-Hsuan Li Division of Thoracic Medicine
- 張育平 Division of Thoracic Medicine
- 陳彥豪 Division of Thoracic Medicine
- 賴建豪 Division of Thoracic Medicine
- 李易濰 Division of Thoracic Medicine
- Chia-Cheng Tseng Division of Thoracic Medicine
- CHIN-CHOU WANG Division of Thoracic Medicine
- 林孟志 Division of Thoracic Medicine
- 陳友木 Division of Thoracic Medicine
- 黃國棟 Division of Thoracic Medicine
- 鍾聿修 Division of Thoracic Medicine
- 王逸熙 Division of Thoracic Medicine
- 林理涵 Division of Thoracic Medicine
- 陳怡豪 Division of Thoracic Medicine
- 趙東瀛 Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
20 participants
-
Global
310 participants
